Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 108166
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.108166
Table 2 Infection rates and severity in the vitamin D and control cohorts during 12-week intervention period
Infection outcome
VD group (n = 60)
Control group (n = 60)
P value
Absolute risk reduction
Infection incidence (%)25% (15/60)45% (27/60)0.0120%
Infection rate per 100 patient-days3.25.80.01
Relative risk reduction44%
95% confidence interval (infection incidence)18.0% to 32.0%36.0% to 54.0%
Severe infections requiring antibiotics (%)10% (6/60)25% (15/60)0.0315%
Hospitalization due to infection (%)5% (3/60)13% (8/60)8%